Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proteomic Changes Before and After Colchicine Treatment in hsCRP-Elevated Coronary Heart Disease Patients
NCT07462325Phase 4Not yet recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of colchicine in coronary heart disease (CHD), sponsored by Chinese Academy of Medical Sciences. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT07462325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07462325.